The drug imatinib has been found to drive cancer into remission in people with chronic myeloid leukemia (CML). But CML often returns when treatment is stopped.
Now, according to a new research by a team from UC-Irvine, imatinib could cure CML under certain circumstances if it is taken over a long enough period of time.
According to mathematician Natalia Komarova and biologist Dominik Wodarz (respectively):
“There is evidence that a complete cure is possible. Several patients have been reported to have no symptoms after two months without therapy, which is thought to suggest a complete cure. This evidence supports our theory. Basically, one …read more